跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml
Approved
THERAPEUTIC
AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml
REMEDICA LTD
🇸🇬 Health Sciences Authority
Approval Date
Apr 22, 1988
Approval ID
f8640cfccfe02ee0
Company
REMEDICA LTD
Type
Therapeutic
Approval Details
Approval Id
f8640cfccfe02ee0
Drug Name
AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml
Product Name
AMOXAPEN 250 FOR ORAL SUSPENSION 250 mg/5 ml
Approval Number
SIN00472P
Approval Date
1988-04-22
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01CA04
Atc Item Name
amoxicillin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
250MG/5ML
AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
250 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 22, 1988
Approval ID
f8640cfccfe02ee0
Type
Therapeutic
Back to HSA Approvals
